Oncology Information Systems Market Size, Share, Revenue, Trends ... - Benzinga
| EKTA-B Stock | SEK 64.35 0.40 0.62% |
About 62% of Elekta AB's investor base is looking to short. The analysis of current outlook of investing in Elekta AB suggests that many traders are alarmed regarding Elekta AB's prospects. The current market sentiment, together with Elekta AB's historical and current headlines, can help investors time the market. In addition, many technical investors use Elekta AB stock news signals to limit their universe of possible portfolio assets.
Elekta |
Oncology Information Systems Market Size, Share, Revenue, Trends ... Benzinga
Read at news.google.com
 |
Elekta AB Fundamental Analysis
We analyze Elekta AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Elekta AB using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Elekta AB based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Current Ratio
Current Ratio Comparative Analysis
Elekta AB is currently under evaluation in current ratio category among its peers. Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
Elekta AB Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Elekta AB stock to make a market-neutral strategy. Peer analysis of Elekta AB could also be used in its relative valuation, which is a method of valuing Elekta AB by comparing valuation metrics with similar companies.
Peers
Elekta AB Related Equities
| SUS | Surgical Science | 0.07 | ||||
| BONEX | Bonesupport Holding | 1.26 | ||||
| ONCO | Oncopeptides | 2.53 | ||||
| SECARE | Swedencare Publ | 2.88 |
Complementary Tools for Elekta Stock analysis
When running Elekta AB's price analysis, check to measure Elekta AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Elekta AB is operating at the current time. Most of Elekta AB's value examination focuses on studying past and present price action to predict the probability of Elekta AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Elekta AB's price. Additionally, you may evaluate how the addition of Elekta AB to your portfolios can decrease your overall portfolio volatility.
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |